Sign up to our newsletter Subscribe
Comparing Access to Orphan Medicinal Products (OMPs) in the United Kingdom and other European countries

Sign up to our newsletter Subscribe
COVID-19 presents numerous ongoing challenges. Research continues into vaccines and antivirals, as well as the known and unknown effects of long covid on individual health and society more broadly. There have also been challenges with access and reimbursement in low and middle-income countries.
An error has occurred, please try again later.